• 1. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 2. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 3. eMethylsorb: rapid quantification of DNA methylation in cancer cells on screen-printed gold electrodes
  Kevin M. Koo,Abu Ali Ibn Sina,Laura G. Carrascosa,Muhammad J. A. Shiddiky Analyst, 2014,139, 6178-6184
• 4. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 5. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzamides
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Benzamides

Recent Advances in the Study of Benzenediazonium,2-(aminocarbonyl)-5-methoxy- (CAS: 86780-25-8) in Chemical Biology and Pharmaceutical Research

The compound Benzenediazonium,2-(aminocarbonyl)-5-methoxy- (CAS: 86780-25-8) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This research brief aims to synthesize the latest findings related to this compound, focusing on its synthesis, biological activity, and potential applications in drug development. The following sections provide a comprehensive overview of the current state of research, highlighting key discoveries and future directions.

Recent studies have elucidated the synthetic pathways for Benzenediazonium,2-(aminocarbonyl)-5-methoxy-, with particular emphasis on optimizing yield and purity. A 2023 publication in the Journal of Medicinal Chemistry detailed a novel catalytic method that significantly improves the efficiency of its synthesis, reducing byproduct formation and enhancing scalability. This advancement is critical for facilitating further pharmacological evaluations and potential industrial-scale production.

In terms of biological activity, preliminary in vitro studies have demonstrated that Benzenediazonium,2-(aminocarbonyl)-5-methoxy- exhibits promising inhibitory effects on specific enzymatic targets associated with inflammatory pathways. For instance, research conducted at the University of Cambridge revealed that the compound acts as a potent inhibitor of cyclooxygenase-2 (COX-2), a key enzyme implicated in inflammation and pain. These findings suggest its potential as a lead compound for developing novel anti-inflammatory agents.

Further investigations into the mechanistic underpinnings of Benzenediazonium,2-(aminocarbonyl)-5-methoxy- have employed advanced computational modeling techniques. Molecular docking studies, as reported in a 2024 Bioorganic & Medicinal Chemistry Letters article, have provided insights into the compound's binding affinity and interaction with target proteins. These simulations corroborate experimental data and offer a structural basis for future modifications to enhance selectivity and efficacy.

Despite these promising results, challenges remain in translating these findings into clinical applications. Pharmacokinetic studies indicate that Benzenediazonium,2-(aminocarbonyl)-5-methoxy- exhibits limited bioavailability, necessitating further structural optimization or formulation strategies to improve its therapeutic potential. Ongoing research is exploring prodrug approaches and nanoparticle-based delivery systems to address these limitations.

In conclusion, Benzenediazonium,2-(aminocarbonyl)-5-methoxy- (CAS: 86780-25-8) represents a compelling area of research in chemical biology and drug discovery. Its unique chemical properties and biological activities position it as a promising candidate for further development. Future studies should focus on overcoming current pharmacokinetic challenges and expanding its therapeutic applications, potentially paving the way for novel treatments in inflammation-related disorders and beyond.

• 38487-91-1(2-Amino-4-methoxybenzamide)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)